# Oli

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/oli

- Industry: Medical Devices & Equipment
- Headquarters: Australia
- Website: www.baymatob.com
- Total disclosed funding: $4.7M
- Latest round: Series A (May 27, 2026)
- Investors on record: 3

## About

Based in New South Wales, Australia, and founded in 2013 by Sarah McDonald, Oli previously known as Baymatob Operations Pty. Ltd., which is artificial intelligence-guided medical equipment to predict and prevent health outcomes for pregnant women and their babies. In May 2026, Oli raised AUD 6.5 million in series A funding from Clare Ventures Limited, Scale Investors, and The University of Sydney - Australia. As of May 2022, the company has 11 employees and is led by Tara Croft as its CEO. 

Baymatob has developed Oli PPH, a sensor, monitoring, and diagnostic platform that detects women who are at higher risk of postpartum hemorrhage and provides critical information on maternal & foetal health an hour before giving birth, enabling medical practitioners to be well prepared for all complications during childbirth and help them to prevent the primary cause of preventable maternal death.

The company intends to use the May 2026 funds to develop its wearable maternal and fetal monitoring technology, complete clinical trials across Australia and the US, advance regulatory approvals, and set up manufacturing and operations.

## Funding rounds

- Series A, May 27, 2026, $4.7M — The University of Sydney - Australia, Scale Investors, Clare Ventures Limited

## Investors

- The University of Sydney - Australia — Series A
- Scale Investors (https://capitalatlas.ai/funds/scale-investors) — Series A
- Clare Ventures Limited — Series A